Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening.

Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen KE, Woodruff JL, Cox E, Mohamed LS, Choo DI, Boppana SB; CHIMES Study.

Pediatrics. 2017 Feb;139(2). pii: e20162128. doi: 10.1542/peds.2016-2128. Epub 2017 Jan 3.

2.

Hearing Loss Detection in Schools and Early Child Care Settings: An Overview of School-Age Hearing Screening Practices.

Winston-Gerson R, Sabo DL.

NASN Sch Nurse. 2016 Sep;31(5):257-62. doi: 10.1177/1942602X16661362. Epub 2016 Aug 1.

PMID:
27481476
3.

Valganciclovir for symptomatic congenital cytomegalovirus disease.

Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

N Engl J Med. 2015 Mar 5;372(10):933-43. doi: 10.1056/NEJMoa1404599.

4.

Call for calibration standard for newborn screening using auditory brainstem responses.

Durrant JD, Sabo DL, Delgado RE.

Int J Audiol. 2007 Nov;46(11):686-91.

PMID:
17978951
5.

Tympanostomy tubes and developmental outcomes at 9 to 11 years of age.

Paradise JL, Feldman HM, Campbell TF, Dollaghan CA, Rockette HE, Pitcairn DL, Smith CG, Colborn DK, Bernard BS, Kurs-Lasky M, Janosky JE, Sabo DL, O'Connor RE, Pelham WE Jr.

N Engl J Med. 2007 Jan 18;356(3):248-61.

6.

Reliability of electric response audiometry using 80 Hz auditory steady-state responses.

Kaf WA, Sabo DL, Durrant JD, Rubinstein E.

Int J Audiol. 2006 Aug;45(8):477-86.

PMID:
17005490
7.

Tympanometric findings and the probability of middle-ear effusion in 3686 infants and young children.

Smith CG, Paradise JL, Sabo DL, Rockette HE, Kurs-Lasky M, Bernard BS, Colborn DK.

Pediatrics. 2006 Jul;118(1):1-13.

PMID:
16818543
8.

Validity and accuracy of electric response audiometry using the auditory steady-state response: evaluation in an empirical design.

Kaf WA, Durrant JD, Sabo DL, Robert Boston J, Taubman LB, Kovacyk K.

Int J Audiol. 2006 Apr;45(4):211-23.

PMID:
16684702
9.

Developmental outcomes after early or delayed insertion of tympanostomy tubes.

Paradise JL, Campbell TF, Dollaghan CA, Feldman HM, Bernard BS, Colborn DK, Rockette HE, Janosky JE, Pitcairn DL, Kurs-Lasky M, Sabo DL, Smith CG.

N Engl J Med. 2005 Aug 11;353(6):576-86.

10.

Development of f2/f1 ratio functions in humans.

Vento BA, Durrant JD, Sabo DL, Boston JR.

J Acoust Soc Am. 2004 May;115(5 Pt 1):2138-47.

PMID:
15139625
11.

Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years.

Paradise JL, Dollaghan CA, Campbell TF, Feldman HM, Bernard BS, Colborn DK, Rockette HE, Janosky JE, Pitcairn DL, Kurs-Lasky M, Sabo DL, Smith CG.

Pediatrics. 2003 Aug;112(2):265-77.

PMID:
12897272
12.

Treatment of children with congenital cytomegalovirus infection with ganciclovir.

Michaels MG, Greenberg DP, Sabo DL, Wald ER.

Pediatr Infect Dis J. 2003 Jun;22(6):504-9.

PMID:
12799506
13.

Risk factors for speech delay of unknown origin in 3-year-old children.

Campbell TF, Dollaghan CA, Rockette HE, Paradise JL, Feldman HM, Shriberg LD, Sabo DL, Kurs-Lasky M.

Child Dev. 2003 Mar-Apr;74(2):346-57.

PMID:
12705559
14.

Early versus delayed insertion of tympanostomy tubes for persistent otitis media: developmental outcomes at the age of three years in relation to prerandomization illness patterns and hearing levels.

Paradise JL, Feldman HM, Campbell TF, Dollaghan CA, Colborn DK, Bernard BS, Rockette HE, Janosky JE, Pitcairn DL, Sabo DL, Kurs-Lasky M, Smith CG.

Pediatr Infect Dis J. 2003 Apr;22(4):309-14.

PMID:
12690269
15.
16.

Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years.

Paradise JL, Feldman HM, Campbell TF, Dollaghan CA, Colborn DK, Bernard BS, Rockette HE, Janosky JE, Pitcairn DL, Sabo DL, Kurs-Lasky M, Smith CG.

N Engl J Med. 2001 Apr 19;344(16):1179-87.

17.

Language, speech sound production, and cognition in three-year-old children in relation to otitis media in their first three years of life.

Paradise JL, Dollaghan CA, Campbell TF, Feldman HM, Bernard BS, Colborn DK, Rockette HE, Janosky JE, Pitcairn DL, Sabo DL, Kurs-Lasky M, Smith CG.

Pediatrics. 2000 May;105(5):1119-30.

PMID:
10790473
18.

Validation by magnetic resonance imaging of tympanometry for diagnosing middle ear effusion.

Alper CM, Sabo DL, Doyle WJ.

Otolaryngol Head Neck Surg. 1999 Nov;121(5):523-7.

PMID:
10547463
19.

The audiologic assessment of the young pediatric patient: the clinic.

Sabo DL.

Trends Amplif. 1999 Jun;4(2):51-60. doi: 10.1177/108471389900400205. No abstract available.

20.
21.

Correlations of neuroanatomical measures to auditory brain stem response latencies.

Sabo DL, Durrant JD, Curtin H, Boston JR, Rood S.

Ear Hear. 1992 Aug;13(4):213-22.

PMID:
1397762
22.

Gender, head size, and ABRs examined in large clinical sample.

Durrant JD, Sabo DL, Hyre RJ.

Ear Hear. 1990 Jun;11(3):210-4.

PMID:
2358132
23.

Masking level difference at relatively high masker levels: preliminary report.

Durrant JD, Nozza RJ, Hyre RJ, Sabo DL.

Audiology. 1989;28(4):221-9.

PMID:
2751490
24.

Conductive hearing loss in infants and young children with cleft palate.

Fria TJ, Paradise JL, Sabo DL, Elster BA.

J Pediatr. 1987 Jul;111(1):84-7. No abstract available.

PMID:
3598793
25.

Auditory brainstem responses in children with otitis media with effusion.

Fria TJ, Sabo DL.

Ann Otol Rhinol Laryngol Suppl. 1980 May-Jun;89(3 Pt 2):200-6.

PMID:
6778307
26.

Identification of otitis media with effusion in children.

Cantekin EI, Bluestone CD, Fria TJ, Stool SE, Beery QC, Sabo DL.

Ann Otol Rhinol Laryngol Suppl. 1980 May-Jun;89(3 Pt 2):190-5.

PMID:
6778304
27.

A guanosine to adenosine transition in the 3' terminal extracistronic region of bacteriophage Q beta RNA leading to loss of infectivity.

Sabo DL, Domingo E, Bandle EF, Flavell RA, Weissmann C.

J Mol Biol. 1977 May 15;112(2):235-52. No abstract available.

PMID:
875018
28.

Biodegradative ornithine decarboxylase of Escherichia coli. Purification, properties, and pyridoxal 5'-phosphate binding site.

Applebaum D, Sabo DL, Fischer EH, Morris DR.

Biochemistry. 1975 Aug 12;14(16):3675-81.

PMID:
240388
29.

Site-directed mutagenesis: effect of an extracistronic mutation on the in vitro propagation of bacteriophage Qbeta RNA.

Flavell RA, Sabo DL, Bandle EF, Weissmann C.

Proc Natl Acad Sci U S A. 1975 Jan;72(1):367-71.

30.

Site-directed mutagenesis: generation of an extracistronic mutation in bacteriophage Q beta RNA.

Flavell RA, Sabo DL, Bandle EF, Weissmann C.

J Mol Biol. 1974 Oct 25;89(2):255-72. No abstract available.

PMID:
4444051
31.

Purification and physical properties of inducible Escherichia coli lysine decarboxylase.

Sabo DL, Boeker EA, Byers B, Waron H, Fischer EH.

Biochemistry. 1974 Feb 12;13(4):662-70. No abstract available.

PMID:
4590109
32.

Chemical properties of Escherichia coli lysine decarboxylase including a segment of its pyridoxal 5'-phosphate binding site.

Sabo DL, Fischer EH.

Biochemistry. 1974 Feb 12;13(4):670-6. No abstract available.

PMID:
4204273

Supplemental Content

Support Center